Ticker > Company >

Johnson Pharmacare share price

Johnson Pharmacare Ltd.

BSE: 532154 SECTOR: Trading  41k   81   10

0.98
+0.01 (1.03%)
BSE: 03 Apr 04:01 PM

Price Summary

Today's High

₹ 0.99

Today's Low

₹ 0.96

52 Week High

₹ 1.44

52 Week Low

₹ 0.78

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

53.9 Cr.

Enterprise Value

55.85 Cr.

No. of Shares

55 Cr.

P/E

0

P/B

0.95

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.03

CASH

0 Cr.

DEBT

1.95 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  0

Sales Growth

-100%

ROE

-0.35 %

ROCE

-0.33%

Profit Growth

84.81 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-100%
3 Year-100%
5 Year-100%

Profit Growth

1 Year84.81%
3 Year-650.79%
5 Year-273.98%

ROE%

1 Year-0.35%
3 Year-0.81%
5 Year-0.52%

ROCE %

1 Year-0.33%
3 Year-0.79%
5 Year-0.5%

Debt/Equity

0.0344

Price to Cash Flow

-1187.22

Interest Cover Ratio

-217

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2024 0.00 0.00
Sep 2024 0.00 0.00
Jun 2024 0.00 0.00
Mar 2024 0.00 0.00
Dec 2023 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 24.2528300300629.

 Limitations

  • The company has shown a poor profit growth of -650.789487143047% for the Past 3 years.
  • The company has shown a poor revenue growth of -100% for the Past 3 years.
  • Company has a poor ROE of -0.807042304075549% over the past 3 years.
  • Company has a poor ROCE of -0.786923703082639% over the past 3 years
  • Company has negative cash flow from operations of -0.0454.
  • The company has a low EBITDA margin of -9.6475321126179% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Net Sales 0 0 0 0 0
Total Expenditure 0.01 0 0.04 0 0.03
Operating Profit -0.01 0 -0.04 0 -0.03
Other Income 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.01 0 -0.04 0 -0.03
Tax 0 0 0 0 0
Profit After Tax -0.01 0 -0.04 0 -0.03
Adjusted EPS (Rs) 0 0 0 0 0

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0.76 3.26 2.53 0
Total Expenditure 0.09 0.76 3.13 3.86 0.2
Operating Profit -0.09 0 0.13 -1.33 -0.2
Other Income 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.09 0 0.13 -1.33 -0.2
Tax 0 0 0.04 -0.04 0
Net Profit -0.09 0 0.1 -1.29 -0.2
Adjusted EPS (Rs.) 0 0 0 -0.02 0

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 50 50 55 55 55
Total Reserves 8.14 8.14 3.24 1.95 1.75
Borrowings 0.63 0.69 0.61 1.91 1.95
Other N/C liabilities 0 0 0 0 0
Current liabilities 0 0.65 1.13 0.98 1.13
Total Liabilities 58.77 59.48 59.98 59.83 59.83
Assets
Net Block 0 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 52.26 52.26 54.18 45.56 45.56
Loans & Advances 1.63 1.63 4.71 14.27 14.27
Other N/C Assets 0 0 0 0 0
Current Assets 4.89 5.6 1.09 0 0
Total Assets 58.77 59.48 59.98 59.83 59.83
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.09 0 0.13 -1.33 -0.2
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities 0.26 -0.11 4.8 0.89 0.15
Tax Paid 0 0 -0.04 0.04 0
Operating Cash Flow 0.17 -0.11 4.9 -0.4 -0.05
Investing Cash Flow 0.88 0 -5.01 -0.94 0
Financing Cash Flow -1.07 0.06 -0.08 1.3 0.05
Net Cash Flow -0.03 -0.05 -0.19 -0.04 0

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
PARTICULARS Dec 2023% Mar 2024% Jun 2024% Sep 2024% Dec 2024%
investors 100.00 100.00 100.00 100.00 100.00
apex commotrade private l... 1.84 1.84 1.84 1.84 1.84
jagkarta agencies private... 2.78 2.78 2.78 2.78 2.78
spice merchants private l... 1.01 1.01 1.01 1.01 1.01

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Johnson Pharmacare - Quaterly Results 31 Jan, 6:50 PM Johnson Pharmacare - Quaterly Results 31 Jan, 6:50 PM Johnson Pharmacare - Quaterly Results 31 Jan, 6:50 PM Johnson Pharmacare informs about AGM notice 5 Sep, 9:59 AM Johnson Pharmacare - Quaterly Results 1 Aug, 5:46 PM Johnson Pharmacare - Quaterly Results 1 Aug, 5:46 PM Johnson Pharmacare - Quaterly Results 1 Aug, 5:46 PM Johnson Pharmacare - Quaterly Results 25 May, 5:47 PM Johnson Pharmacare - Quaterly Results 25 May, 5:47 PM Johnson Pharmacare - Quaterly Results 25 May, 5:47 PM Johnson Pharmacare - Quaterly Results 22 Jan, 5:56 PM Johnson Pharmacare - Quaterly Results 22 Jan, 5:56 PM Johnson Pharmacare informs about board meeting 16 Jan, 5:13 PM Johnson Pharmacare - Quaterly Results 1 Nov, 6:11 PM Johnson Pharmacare - Quaterly Results 1 Nov, 6:11 PM Johnson Pharmacare - Quaterly Results 10 Aug, 6:40 PM Johnson Pharmacare - Quaterly Results 24 May, 4:20 PM Johnson Pharmacare - Quaterly Results 24 May, 4:20 PM Johnson Pharmacare - Quaterly Results 24 May, 4:20 PM Johnson Pharmacare informs about trading window closure 30 Mar, 2:43 PM Johnson Pharmacare - Quaterly Results 2 Feb, 5:57 PM Johnson Pharmacare - Quaterly Results 2 Feb, 5:57 PM Johnson Pharmacare - Quaterly Results 2 Feb, 5:57 PM Johnson Pharmacare - Quaterly Results 9 Nov, 4:43 PM Johnson Pharmacare - Quaterly Results 9 Nov, 4:43 PM Johnson Pharmacare - Quaterly Results 25 Jul, 1:58 PM Johnson Pharmacare - Quaterly Results 25 Jul, 1:58 PM Johnson Pharmacare - Quaterly Results 25 Jul, 1:58 PM Johnson Pharmacare informs about board meeting 7 Jul, 9:47 AM Johnson Pharmacare informs about disclosure on related party transactions 25 May, 4:59 PM Johnson Pharmacare informs about outcome of board meeting 25 May, 4:57 PM Johnson Pharmacare informs about disclosure 4 Apr, 4:18 PM Johnson Pharmacare - Quaterly Results 12 Feb, 3:44 PM Johnson Pharmacare informs about board meeting 17 Jan, 12:08 PM Johnson Pharmacare informs about record date 30 Nov, 4:05 PM Johnson Pharmacare informs about disclosure 22 Nov, 2:55 PM Johnson Pharmacare informs about board meeting 7 Oct, 2:46 PM Johnson Pharmacare informs about closure of trading window 29 Sep, 3:36 PM Sun And Shine Worldwide informs about unaudited financial results 28 Oct, 5:00 PM Sun And Shine Worldwide board to approve un-audited financial results 28 Aug, 3:51 PM Sun And Shine Worldwide informs about disclosure on related party transactions 26 Jun, 2:16 PM

Johnson Pharmacare Stock Price Analysis and Quick Research Report. Is Johnson Pharmacare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Johnson Pharmacare stock price today is Rs 0.98. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Johnson Pharmacare . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Johnson Pharmacare has a PE ratio of -753.846153846154 which is low and comparatively undervalued .

  • Share Price: - The current share price of Johnson Pharmacare is Rs 0.98. One can use valuation calculators of ticker to know if Johnson Pharmacare share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Johnson Pharmacare has ROA of -0.3279 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Johnson Pharmacare has a Current ratio of 0.0012 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Johnson Pharmacare has a ROE of -0.3451 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Johnson Pharmacare has a Debt to Equity ratio of 0.0344 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Johnson Pharmacare has reported revenue growth of -100 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Johnson Pharmacare for the current financial year is 0 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Johnson Pharmacare is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Johnson Pharmacare is Rs -0.0013 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Johnson Pharmacare in Ticker for free. Also, one can get the intrinsic value of Johnson Pharmacare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Johnson Pharmacare
X